Humans spend between 80–95% of their lives inside inhaling more than 10 m3 of indoor air every day.
Pollutants and pathogens suspended in that air can be absorbed into our throats, eyes, lungs and bloodstream, negatively impacting our health, wellbeing, cognition, and performance.
from the World Health Organization
Indoor air can be up to 10 times more polluted than outside air – teeming with volatile organic compounds and microorganisms that contain or attach to viruses, bacteria, fungal spores, and pollen. Exposure to these pollutants can lead to infectious disease, asthma, allergies, headaches and irritation.
Novaerus technology has been shown to safely and effectively reduce bacteria, viruses, VOCs, and particulate matter in dozens of independent laboratory tests.
In case studies and clinical trials, our products have been demonstrated to reduce infections and improve wellbeing in real-world settings.
Infectious aerosols can be extremely small (<5 μm) and remain suspended and viable in the air stream over long periods of time, resulting in a high risk of airborne infection.
Larger infectious particles drop from the air to contaminate surfaces and hands.
Infectious pathogens like MRSA, TB, C. difficile, Norovirus, and Influenza are scientifically proven to be transmitted via indoor air currents.
Get news and updates about Novaerus and indoor air quality,